chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Acute respiratory failure, Asthenia, Blood pressure increased, COVID-19
Clinical narrative: Patient is a 66 y.o. female patient of CNP with history of hypertension hyperlipidemia diabetes mellitus also is known for nonobstructive coronary artery disease with congestive heart failure nonischemic cardiomyopathy with ejection fraction 30 to 35% improved up to 62 according to last echo history of obstructive sleep apnea with morbid obesity is here due to chest pain epigastric pain and weakness noticed to have COVID-positive on arrival to the emergency department and hypoxic with oxygen saturation in the mid 80s improved with nasal cannula at 2 L and elevated blood pressure chest image showed infiltrates   COVID-19 respiratory infection Acute hypoxic respiratory failure Pneumonia due to COVID-19 Chest x-ray showed hazy airspace opacification at the right lung base which may represent pneumonia.  We will place patient on oxygen therapy and telemetry continue supportive measures check inflammatory markers infectious disease consult was placed, start the patient on Decadron and remdesivir  on room air and in no distress ;  Will follow labs with ID  Pt has had all immunizations prior to this Continue with Remdesivir and dexamethasone CT of chest with no sign of pneumonia 4mm right lower lung nodule is benign  Remdesivir completed Room air If ok with Dr will discharge home today   Chest pain - no complaints of - resolved Seem to be atypical and possible pleurisy related we will continue further trend of troponin levels and place patient telemetry  Troponin negative; CT chest 11-19 negative  Will order percocet prn for this complaint   Hypertension  resume home regimen Monitor the trend blood pressure was elevated on arrival, IV hydralazine as needed   Diabetes mellitus We will monitor blood glucose and insulin sliding scale check A1c level Nonischemic cardiomyopathy Chronic CHF with preserved EF known for nonobstructive coronary artery disease with congestive heart failure nonischemic cardiomyopathy with ejection fraction 30 to 35% improved up to 62 according to last echo    obstructive sleep apnea Resume CPAP while here   Morbid obesity  encourage healthier lifestyle
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Chest X-ray abnormal, Chest pain, Computerised tomogram thorax abnormal, Hypoxia
Clinical narrative: Patient is a 66 y.o. female patient of CNP with history of hypertension hyperlipidemia diabetes mellitus also is known for nonobstructive coronary artery disease with congestive heart failure nonischemic cardiomyopathy with ejection fraction 30 to 35% improved up to 62 according to last echo history of obstructive sleep apnea with morbid obesity is here due to chest pain epigastric pain and weakness noticed to have COVID-positive on arrival to the emergency department and hypoxic with oxygen saturation in the mid 80s improved with nasal cannula at 2 L and elevated blood pressure chest image showed infiltrates   COVID-19 respiratory infection Acute hypoxic respiratory failure Pneumonia due to COVID-19 Chest x-ray showed hazy airspace opacification at the right lung base which may represent pneumonia.  We will place patient on oxygen therapy and telemetry continue supportive measures check inflammatory markers infectious disease consult was placed, start the patient on Decadron and remdesivir  on room air and in no distress ;  Will follow labs with ID  Pt has had all immunizations prior to this Continue with Remdesivir and dexamethasone CT of chest with no sign of pneumonia 4mm right lower lung nodule is benign  Remdesivir completed Room air If ok with Dr will discharge home today   Chest pain - no complaints of - resolved Seem to be atypical and possible pleurisy related we will continue further trend of troponin levels and place patient telemetry  Troponin negative; CT chest 11-19 negative  Will order percocet prn for this complaint   Hypertension  resume home regimen Monitor the trend blood pressure was elevated on arrival, IV hydralazine as needed   Diabetes mellitus We will monitor blood glucose and insulin sliding scale check A1c level Nonischemic cardiomyopathy Chronic CHF with preserved EF known for nonobstructive coronary artery disease with congestive heart failure nonischemic cardiomyopathy with ejection fraction 30 to 35% improved up to 62 according to last echo    obstructive sleep apnea Resume CPAP while here   Morbid obesity  encourage healthier lifestyle
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Lung infiltration, Lung opacity, Positive airway pressure therapy, Pulmonary mass, SARS-CoV-2 test positive
Clinical narrative: Patient is a 66 y.o. female patient of CNP with history of hypertension hyperlipidemia diabetes mellitus also is known for nonobstructive coronary artery disease with congestive heart failure nonischemic cardiomyopathy with ejection fraction 30 to 35% improved up to 62 according to last echo history of obstructive sleep apnea with morbid obesity is here due to chest pain epigastric pain and weakness noticed to have COVID-positive on arrival to the emergency department and hypoxic with oxygen saturation in the mid 80s improved with nasal cannula at 2 L and elevated blood pressure chest image showed infiltrates   COVID-19 respiratory infection Acute hypoxic respiratory failure Pneumonia due to COVID-19 Chest x-ray showed hazy airspace opacification at the right lung base which may represent pneumonia.  We will place patient on oxygen therapy and telemetry continue supportive measures check inflammatory markers infectious disease consult was placed, start the patient on Decadron and remdesivir  on room air and in no distress ;  Will follow labs with ID  Pt has had all immunizations prior to this Continue with Remdesivir and dexamethasone CT of chest with no sign of pneumonia 4mm right lower lung nodule is benign  Remdesivir completed Room air If ok with Dr will discharge home today   Chest pain - no complaints of - resolved Seem to be atypical and possible pleurisy related we will continue further trend of troponin levels and place patient telemetry  Troponin negative; CT chest 11-19 negative  Will order percocet prn for this complaint   Hypertension  resume home regimen Monitor the trend blood pressure was elevated on arrival, IV hydralazine as needed   Diabetes mellitus We will monitor blood glucose and insulin sliding scale check A1c level Nonischemic cardiomyopathy Chronic CHF with preserved EF known for nonobstructive coronary artery disease with congestive heart failure nonischemic cardiomyopathy with ejection fraction 30 to 35% improved up to 62 according to last echo    obstructive sleep apnea Resume CPAP while here   Morbid obesity  encourage healthier lifestyle
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Troponin normal
Clinical narrative: Patient is a 66 y.o. female patient of CNP with history of hypertension hyperlipidemia diabetes mellitus also is known for nonobstructive coronary artery disease with congestive heart failure nonischemic cardiomyopathy with ejection fraction 30 to 35% improved up to 62 according to last echo history of obstructive sleep apnea with morbid obesity is here due to chest pain epigastric pain and weakness noticed to have COVID-positive on arrival to the emergency department and hypoxic with oxygen saturation in the mid 80s improved with nasal cannula at 2 L and elevated blood pressure chest image showed infiltrates   COVID-19 respiratory infection Acute hypoxic respiratory failure Pneumonia due to COVID-19 Chest x-ray showed hazy airspace opacification at the right lung base which may represent pneumonia.  We will place patient on oxygen therapy and telemetry continue supportive measures check inflammatory markers infectious disease consult was placed, start the patient on Decadron and remdesivir  on room air and in no distress ;  Will follow labs with ID  Pt has had all immunizations prior to this Continue with Remdesivir and dexamethasone CT of chest with no sign of pneumonia 4mm right lower lung nodule is benign  Remdesivir completed Room air If ok with Dr will discharge home today   Chest pain - no complaints of - resolved Seem to be atypical and possible pleurisy related we will continue further trend of troponin levels and place patient telemetry  Troponin negative; CT chest 11-19 negative  Will order percocet prn for this complaint   Hypertension  resume home regimen Monitor the trend blood pressure was elevated on arrival, IV hydralazine as needed   Diabetes mellitus We will monitor blood glucose and insulin sliding scale check A1c level Nonischemic cardiomyopathy Chronic CHF with preserved EF known for nonobstructive coronary artery disease with congestive heart failure nonischemic cardiomyopathy with ejection fraction 30 to 35% improved up to 62 according to last echo    obstructive sleep apnea Resume CPAP while here   Morbid obesity  encourage healthier lifestyle
Age: 54.0
Sex: F
Vaccine: VARZOS
Symptoms: Blood immunoglobulin G increased, Blood immunoglobulin M increased, Ear infection bacterial, Rash, Rash pruritic
Clinical narrative: widespread pruritic vesicular rash consistent with varicella, followed by secondary bacterial infection right ear
Age: 54.0
Sex: F
Vaccine: VARZOS
Symptoms: Rash vesicular
Clinical narrative: widespread pruritic vesicular rash consistent with varicella, followed by secondary bacterial infection right ear
Age: 76.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure, Angiogram pulmonary abnormal, Atelectasis, COVID-19, COVID-19 pneumonia
Clinical narrative: Patient is a 77 y.o. female patient of DO with a PMHx of atrial fibrillation (on apixaban), breast cancer s/p mastectomy (over 30 years ago), HTN, GERD, osteoporosis, and diet-controlled DM2 admitted for COVID19 pneumonia.      Acute hypoxic respiratory failure  COVID19 pneumonia Sepsis POA secondary to COVID with tachycardia, hypoxia Date of onset of symptoms: 11/21/23 Symptoms present on admission: SOB, fatigue, HA, coughing  Date of positive COVID19 test: 11/22/23  Imaging: CXR on admission negative for infiltrate --CTPA 11/22 neg for PE or infiltrate. Mild emphysema, bibasilar atelectasis noted. Oxygen requirements on admission: 2 L O2 on admit (none at baseline) Current oxygen requirements: RA Medical therapy: remdesivir, steroids,  all started 11/22  - DuoNebs q6h while awake Stopped ROcephin/azithromycin 11/23 as no evidence of secondary bacterial infection Consultants following: None Anticipated special isolation end date: 12/02/23 RA am 11/23, able to walk in room but still significant tachycardia and exertional dyspnea + coughing fits, added mucinex, tessalon Much improved, tachycardia resolved, RA, walking around room without issue, cogh better Will discharge with short course decadron only secondary to rapid improvement and worsening GERD, DM Nonspecfic LAD on CT - has regular follow up with Dr with imaging   PAF Remote DVT Continued home diltiazem and apixaban No evidence of RVR on admission Sinus tachycardia 11/23 , treat COVID Resolved, refill for cardizem ordered     Essential HTN HLD Continued home lisinopril Continued home atorvastatin   Diet controlled DM2 Hgb A1c 9/9/23 - 6.6% Carb consistent diet  Sensitive sliding scale insulin ordered given risk of hyperglycemia while on steroids BG reasonable to date Short course steriods due to hyperglycemia and should resolve when off steriods   GERD Takes prilosec OTC and will take BID at home until off steriods Does not need script
Age: 76.0
Sex: F
Vaccine: COVID19-2
Symptoms: Chest X-ray normal, Cough, Dyspnoea, Dyspnoea exertional, Emphysema
Clinical narrative: Patient is a 77 y.o. female patient of DO with a PMHx of atrial fibrillation (on apixaban), breast cancer s/p mastectomy (over 30 years ago), HTN, GERD, osteoporosis, and diet-controlled DM2 admitted for COVID19 pneumonia.      Acute hypoxic respiratory failure  COVID19 pneumonia Sepsis POA secondary to COVID with tachycardia, hypoxia Date of onset of symptoms: 11/21/23 Symptoms present on admission: SOB, fatigue, HA, coughing  Date of positive COVID19 test: 11/22/23  Imaging: CXR on admission negative for infiltrate --CTPA 11/22 neg for PE or infiltrate. Mild emphysema, bibasilar atelectasis noted. Oxygen requirements on admission: 2 L O2 on admit (none at baseline) Current oxygen requirements: RA Medical therapy: remdesivir, steroids,  all started 11/22  - DuoNebs q6h while awake Stopped ROcephin/azithromycin 11/23 as no evidence of secondary bacterial infection Consultants following: None Anticipated special isolation end date: 12/02/23 RA am 11/23, able to walk in room but still significant tachycardia and exertional dyspnea + coughing fits, added mucinex, tessalon Much improved, tachycardia resolved, RA, walking around room without issue, cogh better Will discharge with short course decadron only secondary to rapid improvement and worsening GERD, DM Nonspecfic LAD on CT - has regular follow up with Dr with imaging   PAF Remote DVT Continued home diltiazem and apixaban No evidence of RVR on admission Sinus tachycardia 11/23 , treat COVID Resolved, refill for cardizem ordered     Essential HTN HLD Continued home lisinopril Continued home atorvastatin   Diet controlled DM2 Hgb A1c 9/9/23 - 6.6% Carb consistent diet  Sensitive sliding scale insulin ordered given risk of hyperglycemia while on steroids BG reasonable to date Short course steriods due to hyperglycemia and should resolve when off steriods   GERD Takes prilosec OTC and will take BID at home until off steriods Does not need script
Age: 76.0
Sex: F
Vaccine: COVID19-2
Symptoms: Fatigue, Glycosylated haemoglobin, Headache, Hypoxia, SARS-CoV-2 test positive
Clinical narrative: Patient is a 77 y.o. female patient of DO with a PMHx of atrial fibrillation (on apixaban), breast cancer s/p mastectomy (over 30 years ago), HTN, GERD, osteoporosis, and diet-controlled DM2 admitted for COVID19 pneumonia.      Acute hypoxic respiratory failure  COVID19 pneumonia Sepsis POA secondary to COVID with tachycardia, hypoxia Date of onset of symptoms: 11/21/23 Symptoms present on admission: SOB, fatigue, HA, coughing  Date of positive COVID19 test: 11/22/23  Imaging: CXR on admission negative for infiltrate --CTPA 11/22 neg for PE or infiltrate. Mild emphysema, bibasilar atelectasis noted. Oxygen requirements on admission: 2 L O2 on admit (none at baseline) Current oxygen requirements: RA Medical therapy: remdesivir, steroids,  all started 11/22  - DuoNebs q6h while awake Stopped ROcephin/azithromycin 11/23 as no evidence of secondary bacterial infection Consultants following: None Anticipated special isolation end date: 12/02/23 RA am 11/23, able to walk in room but still significant tachycardia and exertional dyspnea + coughing fits, added mucinex, tessalon Much improved, tachycardia resolved, RA, walking around room without issue, cogh better Will discharge with short course decadron only secondary to rapid improvement and worsening GERD, DM Nonspecfic LAD on CT - has regular follow up with Dr with imaging   PAF Remote DVT Continued home diltiazem and apixaban No evidence of RVR on admission Sinus tachycardia 11/23 , treat COVID Resolved, refill for cardizem ordered     Essential HTN HLD Continued home lisinopril Continued home atorvastatin   Diet controlled DM2 Hgb A1c 9/9/23 - 6.6% Carb consistent diet  Sensitive sliding scale insulin ordered given risk of hyperglycemia while on steroids BG reasonable to date Short course steriods due to hyperglycemia and should resolve when off steriods   GERD Takes prilosec OTC and will take BID at home until off steriods Does not need script
Age: 76.0
Sex: F
Vaccine: COVID19-2
Symptoms: Sepsis, Sinus tachycardia, Tachycardia
Clinical narrative: Patient is a 77 y.o. female patient of DO with a PMHx of atrial fibrillation (on apixaban), breast cancer s/p mastectomy (over 30 years ago), HTN, GERD, osteoporosis, and diet-controlled DM2 admitted for COVID19 pneumonia.      Acute hypoxic respiratory failure  COVID19 pneumonia Sepsis POA secondary to COVID with tachycardia, hypoxia Date of onset of symptoms: 11/21/23 Symptoms present on admission: SOB, fatigue, HA, coughing  Date of positive COVID19 test: 11/22/23  Imaging: CXR on admission negative for infiltrate --CTPA 11/22 neg for PE or infiltrate. Mild emphysema, bibasilar atelectasis noted. Oxygen requirements on admission: 2 L O2 on admit (none at baseline) Current oxygen requirements: RA Medical therapy: remdesivir, steroids,  all started 11/22  - DuoNebs q6h while awake Stopped ROcephin/azithromycin 11/23 as no evidence of secondary bacterial infection Consultants following: None Anticipated special isolation end date: 12/02/23 RA am 11/23, able to walk in room but still significant tachycardia and exertional dyspnea + coughing fits, added mucinex, tessalon Much improved, tachycardia resolved, RA, walking around room without issue, cogh better Will discharge with short course decadron only secondary to rapid improvement and worsening GERD, DM Nonspecfic LAD on CT - has regular follow up with Dr with imaging   PAF Remote DVT Continued home diltiazem and apixaban No evidence of RVR on admission Sinus tachycardia 11/23 , treat COVID Resolved, refill for cardizem ordered     Essential HTN HLD Continued home lisinopril Continued home atorvastatin   Diet controlled DM2 Hgb A1c 9/9/23 - 6.6% Carb consistent diet  Sensitive sliding scale insulin ordered given risk of hyperglycemia while on steroids BG reasonable to date Short course steriods due to hyperglycemia and should resolve when off steriods   GERD Takes prilosec OTC and will take BID at home until off steriods Does not need script
Age: 27.0
Sex: F
Vaccine: TD
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Numbness in my leg/foot two days afterwards. The numbness/tingling is non stop in my leg.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Chest discomfort, Dyspnoea, Electrocardiogram, Fatigue
Clinical narrative: Migraine, nausea, tachycardia, L leg pain and pulling (front of thigh, back of calf), heaviness of heart, SOB, irritability, fatigue,
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Irritability, Migraine, Muscle contracture, Nausea, Pain in extremity
Clinical narrative: Migraine, nausea, tachycardia, L leg pain and pulling (front of thigh, back of calf), heaviness of heart, SOB, irritability, fatigue,
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Tachycardia, Ultrasound scan, Urine analysis
Clinical narrative: Migraine, nausea, tachycardia, L leg pain and pulling (front of thigh, back of calf), heaviness of heart, SOB, irritability, fatigue,
Age: 37.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Coronary artery occlusion, Myocardial infarction
Clinical narrative: Had a massive heart attack on 03/25/2022 100% blockage in LAD
Age: 1.0
Sex: F
Vaccine: HEPA, MMR, VARCEL
Symptoms: Balance disorder, Crying, Gait disturbance, Pyrexia, Synovitis
Clinical narrative: Developed hives + fever 8 days following the vaccines, we were told to expect this. This lasted for 2 nights. On 8/7, we noticed that our child, who had just recently started walking about 2 weeks prior, seemed more off balance and wasn't walking as far. By 8/14, she had completely stopped walking and was actively avoiding putting weight on left lower extremity, holding limb off the floor and crying when she would stand. This prompted us to take her in to the Emergency Dept. She was diagnosed with toxic synovitis as an adverse reaction to the vaccine, and treated with over the counter NSAIDs (Motrin) 3 x per day x 1 week. Started walking and weightbearing on leg after 2 days of being on consistent anti-inflammatories.
Age: 1.0
Sex: F
Vaccine: HEPA, MMR, VARCEL
Symptoms: Ultrasound scan normal, Urticaria, Weight bearing difficulty, X-ray limb normal
Clinical narrative: Developed hives + fever 8 days following the vaccines, we were told to expect this. This lasted for 2 nights. On 8/7, we noticed that our child, who had just recently started walking about 2 weeks prior, seemed more off balance and wasn't walking as far. By 8/14, she had completely stopped walking and was actively avoiding putting weight on left lower extremity, holding limb off the floor and crying when she would stand. This prompted us to take her in to the Emergency Dept. She was diagnosed with toxic synovitis as an adverse reaction to the vaccine, and treated with over the counter NSAIDs (Motrin) 3 x per day x 1 week. Started walking and weightbearing on leg after 2 days of being on consistent anti-inflammatories.
Age: 76.0
Sex: F
Vaccine: RSV
Symptoms: Decreased appetite, Injection site reaction, Oropharyngeal pain, Pain in jaw, Urticaria
Clinical narrative: Lack of appetite, welt at injection site 6 days later, left tonsil hurt, jaw hurt. Not sure which rsv shot it was
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Chapped lips, Deafness, Dry mouth, Eating disorder, Hypoacusis
Clinical narrative: 2-3 weeks after receiving the vaccine, developed dry mouth, chapped lips and irritation when eating (even non-spicy foods).  Had poor hearing before vaccine and hearing loss got worse.  loss of clarity in hearing words.
Sex: U
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Redness, itchiness, skin hot to touch, left shoulder and bicep swelling by 7am the following day, Saturday.  By 7am Sunday, under arm area on the left side was swollen.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Immediate post-injection reaction, No adverse event, Underdose
Clinical narrative: A family of six came in for COVID vaccines.  The father came in a few minutes late requesting COVID and flu vaccines.    After preparation of vaccines, the family was brought into exam room.  I was accompanied by another nurse to assist if needed.  The identity of each family member was validated, and other pertinent information reviewed.  The COVID vaccine was administered to one of the children, after which, the parents requested flu vaccines for the rest of the family.  The other nurse went to prepare the vaccines at my request.  Immediately after administration of the COVID vaccine to pt. it was discovered the he was inadvertently given the pediatric dose of the COVID vaccine.  There were no symptoms and no treatment needed.
Age: 63.0
Sex: M
Vaccine: FLU4
Symptoms: Acute kidney injury, Acute myocardial infarction, Anaemia, Chronic obstructive pulmonary disease, Condition aggravated
Clinical narrative: pt was presented to hospital 5 days after vaccination with hypertension crisis, NSTEMI, Acute kidney injury, COPD flare and anemia.
Age: 63.0
Sex: M
Vaccine: FLU4
Symptoms: Hypertensive crisis
Clinical narrative: pt was presented to hospital 5 days after vaccination with hypertension crisis, NSTEMI, Acute kidney injury, COPD flare and anemia.
Age: 52.0
Sex: M
Vaccine: FLU4
Symptoms: Autopsy, Coronary artery disease, Death, Dilated cardiomyopathy
Clinical narrative: found dead at home 9/27/23
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Chills, Dyspnoea, Feeding disorder, Hypersomnia
Clinical narrative: I became very sick 2 weeks after my second vaccine shot. I was unable to eat, had the chills, shortness of breath,  had no energy, constant sleeping, constant throw up of everything I ate,  right leg started to become limp due to clot behind knee.
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Hypotonia, Malaise, Thrombosis, Vomiting
Clinical narrative: I became very sick 2 weeks after my second vaccine shot. I was unable to eat, had the chills, shortness of breath,  had no energy, constant sleeping, constant throw up of everything I ate,  right leg started to become limp due to clot behind knee.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Computerised tomogram head abnormal, Dizziness, Dysarthria, Facial paralysis
Clinical narrative: Admit date: 12/20/2023  Discharge date: 12/22/2023  Admitting Physician: MD   Attending Physician at the Time of Discharge: DO  Primary Care Physician: NP Reason for Admission: Subarachnoid hemorrhage, non traumatic  Brief Summary of Hospital Stay:As per H&P Patient is an 85-year-old female with history of PAF on Eliquis, hypertension, hyperlipidemia, hypothyroidism, RA, and previous stroke with residual left-sided deficits who presents today for weakness and ground level fall.  Patient states she has been increasingly weak over the past several days but reports the weakness is general and that her left-sided weakness is at baseline.  She has had 2 ground level falls recently, reportedly sliding to the floor without hitting her head.  She denies loss of consciousness  Patient noted feeling lightheaded this morning but denies dizziness.  Family states she had left-sided facial droop and slurred speech after her fall today, so they brought her to the emergency department. Patient denies any further concerns at this time. She states her husband recently tested positive for COVID so she was prescribed antivirals, most recent dose yesterday morning.  Because of this, she has been holding her statin.  She reports eating and drinking as usual.   Hospital Course: Initial CT head w/o contrast showing 2-3mm hyperdensity in left parietal lobe concerning for intraparenchemal vs subarachnoid hemorrhage. Repeat non-contrast head CT showed decreased conspicuity of the small focus of hyperintensity in the left parietal lobe. Neurosurgery consulted, plan to sign off. Suspect non-traumatic bleed - Holding home Eliquis, ASA and NSAIDS for 2 weeks.   Upon exam this morning, patient feeling overall better. PT/OT recommend home with home therapies. Patient was medically optimized. Vital signs were stable for discharge. Discharged to Home Health Care Svc.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Fall, Hemiparesis, Subarachnoid haemorrhage
Clinical narrative: Admit date: 12/20/2023  Discharge date: 12/22/2023  Admitting Physician: MD   Attending Physician at the Time of Discharge: DO  Primary Care Physician: NP Reason for Admission: Subarachnoid hemorrhage, non traumatic  Brief Summary of Hospital Stay:As per H&P Patient is an 85-year-old female with history of PAF on Eliquis, hypertension, hyperlipidemia, hypothyroidism, RA, and previous stroke with residual left-sided deficits who presents today for weakness and ground level fall.  Patient states she has been increasingly weak over the past several days but reports the weakness is general and that her left-sided weakness is at baseline.  She has had 2 ground level falls recently, reportedly sliding to the floor without hitting her head.  She denies loss of consciousness  Patient noted feeling lightheaded this morning but denies dizziness.  Family states she had left-sided facial droop and slurred speech after her fall today, so they brought her to the emergency department. Patient denies any further concerns at this time. She states her husband recently tested positive for COVID so she was prescribed antivirals, most recent dose yesterday morning.  Because of this, she has been holding her statin.  She reports eating and drinking as usual.   Hospital Course: Initial CT head w/o contrast showing 2-3mm hyperdensity in left parietal lobe concerning for intraparenchemal vs subarachnoid hemorrhage. Repeat non-contrast head CT showed decreased conspicuity of the small focus of hyperintensity in the left parietal lobe. Neurosurgery consulted, plan to sign off. Suspect non-traumatic bleed - Holding home Eliquis, ASA and NSAIDS for 2 weeks.   Upon exam this morning, patient feeling overall better. PT/OT recommend home with home therapies. Patient was medically optimized. Vital signs were stable for discharge. Discharged to Home Health Care Svc.
Age: 45.0
Sex: F
Vaccine: COVID19-2
Symptoms: Pain, Pain in extremity
Clinical narrative: My left arm hurt extremely badly almost immediately after getting the shot.  The worst pain from a vaccination that I have ever experienced. It's now been over a year and I still experience pain in my left arm near the injection area when lifting it laterally (away from my body to the side).
Sex: M
Vaccine: VARZOS
Symptoms: Eosinophil count normal, Urticaria
Clinical narrative: hives all over my body; This non-serious case was reported by a consumer and described the occurrence of hives in a 66-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 10-JUL-2023, the patient received the 1st dose of Shingrix. On 11-JUL-2023, 1 days after receiving Shingrix, the patient experienced hives (Verbatim: hives all over my body). The patient was treated with acrivastine (Benadryl), methylprednisolone, montelukast and loratadine. The outcome of the hives was not resolved.   It was unknown if the reporter considered the hives to be related to Shingrix.     It was unknown if the company considered the hives to be related to Shingrix.   Linked case(s) involving the same patient:  US2023AMR181870   Additional Information: GSK Receipt Date: 31-DEC-2023 The patient self reported this case. The patient received his initial Shingrix vaccine shot and by 13th July 2023, he was covered in hives all over his body. The patient thought that it was an allergy and he started taking Benadryl.  On 16th August 2023, the patient went to his primary care physician (PCP) and he was given a steroid shot and Methylprednisolone 6 day pack. With no improvement, the patient went back to his PCP. On 28th August 2023, bloodwork confirmed no elevated eosinophils and patient was prescribed Loratadine (2 per day) and Montelukast (1 per day). On 1st September 2023, the patient went to his dermatologist. She explained that something was causing his mast cells to fracture releasing histamine causing the hives. She recommended continuing with the Loratadine. The reporter consented to follow-up. For tolerance of 2nd dose refer case US2023AMR181870.; Sender's Comments:  US-GSK-US2023AMR181870:Same reporter
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site swelling, Lymphadenopathy
Clinical narrative: Redness, swelling, soreness at injection site and swollen lymph nodes in armpit.
Age: 67.0
Sex: M
Vaccine: RSV
Symptoms: Product preparation issue
Clinical narrative: reports a patient could have received an incomplete dose of Arexvy; contained the adjuvant only and was not reconstituted; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 67-year-old male patient who received RSVPreF3 adjuvanted (Arexvy) (batch number X7P97, expiry date 04-SEP-2026) for prophylaxis.   On 27-DEC-2023, the patient received Arexvy (intramuscular). On 27-DEC-2023, an unknown time after receiving Arexvy, the patient experienced inappropriate preparation of medication (Verbatim: reports a patient could have received an incomplete dose of Arexvy) and inappropriate dose of vaccine administered (Verbatim: contained the adjuvant only and was not reconstituted). The outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 28-DEC-2023 The pharmacist reported that a patient could have received an incomplete dose of Arexvy. The reporter reported that patient could have received a dose of Arexvy that contained the adjuvant only and was not reconstituted, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. The reporter was uncertain if this patient received a complete dose or not. The reported consented to follow up.
Age: 66.0
Sex: F
Vaccine: HEP
Symptoms: Product administered to patient of inappropriate age, Underdose
Clinical narrative: pediatric dose of Engerix-B was inadvertently given to an adult patient; pediatric dose of Engerix-B was inadvertently given to an adult patient; This non-serious case was reported by a other health professional via call center representative and described the occurrence of accidental underdose in a 66-year-old female patient who received HBV (Engerix B pediatric) (batch number 333M4, expiry date 07-APR-2024) for prophylaxis.   On 16-DEC-2023, the patient received Engerix B pediatric. On 16-DEC-2023, an unknown time after receiving Engerix B pediatric, the patient experienced accidental underdose (Verbatim: pediatric dose of Engerix-B was inadvertently given to an adult patient) and adult use of a child product (Verbatim: pediatric dose of Engerix-B was inadvertently given to an adult patient). The outcome of the accidental underdose and adult use of a child product were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt date: 28-DEC-2023 Medical assistant stated that a pediatric dose of Engerix-B was inadvertently given to an adult patient, which led to accidental under dose and adult use child product. The vaccine administration facility was the same as primary reporter. The reporter consented to follow-up.
Sex: U
Vaccine: IPV
Symptoms: No adverse event, Product storage error
Clinical narrative: medication error due to temp. excursion Max/low temperature reached: 1.2 C for 1 min not due to human error but ipol was administered post excursion with no reported adverse event; Initial information received on 20-Dec-2023 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a patient of an unknown age and gender who had administered IPV (VERO) [IPOL] after exposed to temperature reached: 1.2 Celsius for 1 min not due to human error with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a unknown dose of suspect IPV (Vero) Suspension for injection (strength: unknown and expiry date: 02-Jun-2024, lot V1B901M via unknown route in unknown administration site as Immunization and due to temperature excursion reached: 1.2 Celsius for 1 min not due to human error with no reported adverse event (poor quality product administered) (same day latency).   Reportedly: This is an excursion which happened last 14APR2023. Reason: The data logger incrementally got worse. Previous Excursion: No; Human error: No. The extended stability data was cover the excursion for the ADACEL and not for the punctured IPOL.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, Viral pharyngitis
Clinical narrative: viral sore; Covid-19; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (Covid-19) and VIRAL PHARYNGITIS (viral sore) in a  patient of an unknown age and gender who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (unknown route) 1 dosage form. In December 2023, the patient experienced COVID-19 (Covid-19). On 25-Dec-2023, the patient experienced VIRAL PHARYNGITIS (viral sore). At the time of the report, COVID-19 (Covid-19) and VIRAL PHARYNGITIS (viral sore) outcome was unknown.        The action taken with SPIKEVAX NOS (SPIKEVAX NOS) (Unknown) was unknown.       No concomitant medication was reported.  It was reported that patient had all of the Moderna vaccines The initial ones and the boosters and now patient had, actually, after three years patient had covid. But last night patient developed a viral sore, it was not raves but it's on the top of pallet on top of the teeth. No treatment medication was reported.   Reporter did not allow further contact
Age: 39.0
Sex: M
Vaccine: FLU4
Symptoms: Wrong product administered
Clinical narrative: Patient was given an Influenza vaccine vs the tetanus vaccine that was requested. Have made numerous attempts to contact patient to let him know. Unable to reach patient via phone.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Pain in extremity
Clinical narrative: COMIRNATY VACCINE (PLASTIC TUBE) WAS ADMINISTERED ON 12/23/2023. THE VACCINE WAS RECEIVED ON 10/12/2023, THE 10 WEEKS WAS ON 12-20-2023, SO THE VACCINE WAS ADMINISTERED THREE DAYS AFTER THE 10 WEEKS. PATIENT WAS CONTACTED AND THE SITUATION WAS EXPLAINED. WE RECOMMENDED TO WAS CONTACT HER DOCTOR WHO KNOWS HER HEALTH PROFILE AND CAN DO A BETTER SUGGESTION IN REGARDS REVACCINATION OR NOT.                                                                                  SHE REPORTED ARM AND LOWER BACK PAIN FOR ONE DAY.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: COMIRNATY VACCINE (PLASTIC TUBE) WAS ADMINISTERED ON 12/23/2023. THE VACCINE WAS RECEIVED ON 10/12/2023, THE 10 WEEKS WAS ON 12-20-2023, SO THE VACCINE WAS ADMINISTERED THREE DAYS AFTER THE 10 WEEKS. PATIENT WAS CONTACTED AND THE SITUATION WAS EXPLAINED. WE RECOMMENDED TO CONTACT HIS DOCTOR WHO KNOWS HIM HEALTH PROFILE AND CAN DO A BETTER SUGGESTION IN REGARDS REVACCINATION OR NOT.                                                                                  HE REPORTED ARM PAIN.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: COMIRNATY VACCINE (PLASTIC TUBE) WAS ADMINISTERED ON 12/24/2023. THE VACCINE WAS RECEIVED AT THE PHARMACY ON 10/12/2023, THE 10 WEEKS FOR EXPIRATION WAS ON 12-20-2023, SO THE VACCINE WAS ADMINISTERED FOUR DAYS AFTER THE 10 WEEKS. PATIENT WAS CONTACTED AND THE SITUATION WAS EXPLAINED. WE RECOMMENDED TO CONTACT HER DOCTOR WHO KNOWS HER HEALTH PROFILE AND CAN DO A BETTER SUGGESTION IN REGARDS REVACCINATION OR NOT.  SHE DIDN'T REPORTED ANY SIDE EFFECTS OR ADVERSE EVENT.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Cardiac arrest, Cardio-respiratory arrest, Death, Dyspnoea
Clinical narrative: Admit date: 12/11/2023   Discharge date: 12/22/2023   Admitting Physician: MD    Discharge Physician: MD   Reason for Admission: COVID plus community-acquired pneumonia   Hospital Course:   Per note of DO: "Patient is a 86-year-old male with a past medical history of hypertension, type 2 diabetes mellitus prostate cancer with bone metastasis who presents with shortness of breath.  Found to have COVID plus community-acquired pneumonia.  Due to generalized worsening antibiotics broad to cefepime but was still having fevers and encephalopathy.  Cefepime switched to Zosyn to see if this was contributing to encephalopathy. Fever resolved and AMS improving with switch to Zosyn,  Lumbar puncture negative for meningitis.  Neurology did not recommend any other testing.  Possibly just COVID encephalitis vs hospital delirium. "   Reportedly patient was found in bed cold and unresponsive about 45 minutes after being checked previously. CODE BLUE was called and CPR  was initiated. Cardiac rhythm of asystole did not respond to three rounds of epinephrine. Time of death pronounced at 0525.  Attempted to call wife; call directly went to voicemail; message left requesting wife to call the hospital.    Procedures:  MRI brain negative for acute illness LP not suggestive of meningitis   Consults: Neurology   Discharge Problem List      * (Principal) Acute respiratory insufficiency   Type 2 diabetes mellitus with hyperglycemia, without long-term current use of insulin   COVID   CAP (community acquired pneumonia)   Acute encephalopathy     Wt Readings from Last 1 Encounters: 12/21/23 82.1 kg (180 lb 14.4 oz)   Discharged Condition: Deceased
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Encephalopathy, Lumbar puncture normal, Mental status changes, Peripheral coldness, Pneumonia
Clinical narrative: Admit date: 12/11/2023   Discharge date: 12/22/2023   Admitting Physician: MD    Discharge Physician: MD   Reason for Admission: COVID plus community-acquired pneumonia   Hospital Course:   Per note of DO: "Patient is a 86-year-old male with a past medical history of hypertension, type 2 diabetes mellitus prostate cancer with bone metastasis who presents with shortness of breath.  Found to have COVID plus community-acquired pneumonia.  Due to generalized worsening antibiotics broad to cefepime but was still having fevers and encephalopathy.  Cefepime switched to Zosyn to see if this was contributing to encephalopathy. Fever resolved and AMS improving with switch to Zosyn,  Lumbar puncture negative for meningitis.  Neurology did not recommend any other testing.  Possibly just COVID encephalitis vs hospital delirium. "   Reportedly patient was found in bed cold and unresponsive about 45 minutes after being checked previously. CODE BLUE was called and CPR  was initiated. Cardiac rhythm of asystole did not respond to three rounds of epinephrine. Time of death pronounced at 0525.  Attempted to call wife; call directly went to voicemail; message left requesting wife to call the hospital.    Procedures:  MRI brain negative for acute illness LP not suggestive of meningitis   Consults: Neurology   Discharge Problem List      * (Principal) Acute respiratory insufficiency   Type 2 diabetes mellitus with hyperglycemia, without long-term current use of insulin   COVID   CAP (community acquired pneumonia)   Acute encephalopathy     Wt Readings from Last 1 Encounters: 12/21/23 82.1 kg (180 lb 14.4 oz)   Discharged Condition: Deceased
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, Resuscitation, Unresponsive to stimuli
Clinical narrative: Admit date: 12/11/2023   Discharge date: 12/22/2023   Admitting Physician: MD    Discharge Physician: MD   Reason for Admission: COVID plus community-acquired pneumonia   Hospital Course:   Per note of DO: "Patient is a 86-year-old male with a past medical history of hypertension, type 2 diabetes mellitus prostate cancer with bone metastasis who presents with shortness of breath.  Found to have COVID plus community-acquired pneumonia.  Due to generalized worsening antibiotics broad to cefepime but was still having fevers and encephalopathy.  Cefepime switched to Zosyn to see if this was contributing to encephalopathy. Fever resolved and AMS improving with switch to Zosyn,  Lumbar puncture negative for meningitis.  Neurology did not recommend any other testing.  Possibly just COVID encephalitis vs hospital delirium. "   Reportedly patient was found in bed cold and unresponsive about 45 minutes after being checked previously. CODE BLUE was called and CPR  was initiated. Cardiac rhythm of asystole did not respond to three rounds of epinephrine. Time of death pronounced at 0525.  Attempted to call wife; call directly went to voicemail; message left requesting wife to call the hospital.    Procedures:  MRI brain negative for acute illness LP not suggestive of meningitis   Consults: Neurology   Discharge Problem List      * (Principal) Acute respiratory insufficiency   Type 2 diabetes mellitus with hyperglycemia, without long-term current use of insulin   COVID   CAP (community acquired pneumonia)   Acute encephalopathy     Wt Readings from Last 1 Encounters: 12/21/23 82.1 kg (180 lb 14.4 oz)   Discharged Condition: Deceased
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Acute psychosis, Delusion
Clinical narrative: DO Last attending   Treatment team Acute psychosis   Discharge Summary DO (Resident)   Emergency Medicine Cosigned by: DO at 12/25/2023  9:17 AM  Attestation signed by, DO at 12/25/2023  9:17 AM  I was physically present for the key or critical portions of the Evaluation and Management services performed by the resident. I personally evaluated and examined the patient. I participated and discussed the case with the resident and agree with the findings and the plan as documented in the resident's note.   Discharge Summary  Patient here for acute psychosis with dangerous delusions.  Patient will be admitted to the hospitalist service for further evaluation with psychiatry on consult.Dr. will be on consult. Left Against Medical Advice
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Immediate post-injection reaction
Clinical narrative: Pt started feeling dizzy immediately after vaccine was given. BP 160/80. Diaphoretic. After 1 hour, pt was continuing to have the same side effects. Doctor referred to ER. Pt given BP medication at ER and sent home. Pt still feeling dizzy 4 days later.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Acute kidney injury, Anaemia of chronic disease, Back pain, COVID-19, Chronic kidney disease
Clinical narrative: Admit date: 12/19/2023  Discharge date: 12/26/2023   Admitting Physician: MD   Discharge Physician: MD  Reason for Admission: syncope   Discharge Problem List     Acute cystitis without hematuria   Syncope   COVID-19 virus infection   Epilepsy   Hypothyroidism   Chronic back pain   CKD stage G3b/A1, GFR 30-44 and albumin creatinine ratio <30 mg/g (*)   Gout   Normocytic anemia   Type 2 diabetes mellitus, without long-term current use of insulin (HCC)  Procedures: None.    Consultations: None   Hospital Course:  Patient had been feeling poorly for a week and reportedly had an episode of Syncope and had a ground level fall but apparently no significant injuries, some bruising.  Syncope may have been from volume loss with poor oral intake and diarrhea that led to acute on chronic kidney injury with background of CKD stage G3b/A1, GFR 30-44.  Improved with hydration and no further syncope.  Found to have  COVID-19 virus infection but has not been hypoxic so was not started on targeted therapy.  Noted to have Acute cystitis without hematuria with culture growing. E.coli.   Received three days of CEFTRIAXONE  Epilepsy LEVETIRACETAM  Hypothyroidism LEVOTHYROXINE Gout  ALLOPURINOL no active disease  Chronic back pain chronic pain medication  Type 2 diabetes mellitus, without long-term current use of insulin on sliding scale  Normocytic anemia likely of chronic disease. Discharge disposition: Rehab Facility / Unit
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Culture positive, Cystitis, Diarrhoea, Epilepsy
Clinical narrative: Admit date: 12/19/2023  Discharge date: 12/26/2023   Admitting Physician: MD   Discharge Physician: MD  Reason for Admission: syncope   Discharge Problem List     Acute cystitis without hematuria   Syncope   COVID-19 virus infection   Epilepsy   Hypothyroidism   Chronic back pain   CKD stage G3b/A1, GFR 30-44 and albumin creatinine ratio <30 mg/g (*)   Gout   Normocytic anemia   Type 2 diabetes mellitus, without long-term current use of insulin (HCC)  Procedures: None.    Consultations: None   Hospital Course:  Patient had been feeling poorly for a week and reportedly had an episode of Syncope and had a ground level fall but apparently no significant injuries, some bruising.  Syncope may have been from volume loss with poor oral intake and diarrhea that led to acute on chronic kidney injury with background of CKD stage G3b/A1, GFR 30-44.  Improved with hydration and no further syncope.  Found to have  COVID-19 virus infection but has not been hypoxic so was not started on targeted therapy.  Noted to have Acute cystitis without hematuria with culture growing. E.coli.   Received three days of CEFTRIAXONE  Epilepsy LEVETIRACETAM  Hypothyroidism LEVOTHYROXINE Gout  ALLOPURINOL no active disease  Chronic back pain chronic pain medication  Type 2 diabetes mellitus, without long-term current use of insulin on sliding scale  Normocytic anemia likely of chronic disease. Discharge disposition: Rehab Facility / Unit